06/18/2025
5:02 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:30 PM | Avidity Biosciences (Issuer)
Skerjanec Simona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:35 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:37 PM | Avidity Biosciences (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:40 PM | Avidity Biosciences (Issuer)
BOESS CARSTEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:42 PM | Avidity Biosciences (Issuer)
Henig Noreen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:18 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:20 PM | Avidity Biosciences (Issuer)
Kim Jean Jinsun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:24 PM | Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:26 PM | Avidity Biosciences (Issuer)
WILSON TROY EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:31 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for RNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
06/10/2025
3:51 PM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:05 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
3:48 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:37 PM | Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
11:15 AM | Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
6:55 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:56 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
7:50 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
5:38 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:40 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:42 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:44 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:36 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:23 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:35 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:17 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:59 PM | Avidity Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:13 PM | Avidity Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
10:24 AM | Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
4:01 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:34 PM | Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
7:12 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:14 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:15 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:17 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:06 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:08 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:10 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump Makes Major Crypto Announcement (Ad) Pay close attention to what I'm about to share…
Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong.
One project stands to benefit more than any other – not by accident, but seemingly by design.
 Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! |
01/22/2025
3:25 PM | Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:35 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:22 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:24 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:26 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:29 PM | Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:31 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:13 PM | Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:14 PM | Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:16 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:52 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
6:04 PM | Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:42 PM | Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:46 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
8:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
5:15 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:15 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:16 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:17 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:46 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
5:08 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:59 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
5:06 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
5:10 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | Avidity Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
8:39 AM | Avidity Biosciences (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G | |
11/12/2024
6:06 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:50 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
12:56 PM | Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/04/2024
9:22 AM | Avidity Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/30/2024
7:01 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
3:19 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
3:21 PM | Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:20 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
12:48 PM | Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
4:23 PM | Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:36 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024
7:59 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:01 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:03 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:06 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:27 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
4:19 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:25 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:18 PM | Avidity Biosciences (Subject)
McCarthy Teresa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:18 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:26 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:46 PM | Avidity Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
08/21/2024
3:30 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
08/15/2024
3:43 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/15/2024
3:46 PM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:20 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/09/2024
4:12 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/09/2024
3:20 PM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:23 PM | Avidity Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
4:46 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:11 AM | Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
